Trading statement LITHA HEALTHCARE GROUP LIMITED (Incorporated in the Republic of South Africa) (Registration number 2006/006371/06) Share code: LHG ISIN: ZAE000144671 ("Litha”) TRADING STATEMENT Litha is currently finalising its results for the financial year ended 31 December 2013, which is scheduled for release on SENS on or about 7 March 2014. In this regard, shareholders are advised that earnings per share is expected to be between 80% and 100% lower and headline earnings per share is expected to be between 40% and 60% lower than for the financial year ended 31 December 2012. This decrease in earnings is primarily attributable to the following factors: - the once-off profit of R171 529 531 recognised in 2012 associated with the deconsolidation of the Biologicals and Vaccines Institute of Southern Africa Pty Ltd. This once-off profit was included in earnings per share for the financial year ended 31 December 2012(and not headline earnings per share) and represented 79% of the 2012 earnings before taxation; and - the continued devaluation of the South African Rand which increased the cost of imported products. The financial information on which this trading statement is based has not been reviewed and reported on by Litha’s external auditors. Midrand 21 February 2014 Merchant Bank and Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 21/02/2014 11:29:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.